The independent medical news service
24-10-2018 | Head and neck cancer | Video
De-ESCALaTE HPV results revealed
Hisham Mehanna describes the results of the De-ESCALaTE HPV trial comparing cetuximab versus cisplatin for the treatment of low-risk oropharyngeal cancer patients undergoing radiotherapy (5:43).
Pills in hand/© stock_colors / Getty Images / iStock, Male & female outlines_chalk/© TimArbaev / iStock / Thinkstock, Hisham Mehanna/© Lynda Williams, Barbara Burtness